Researchers from Massachusetts General Hospital and Harvard Medical School have developed a primary palliative care framework to improve cystic fibrosis (CF) patient care and reduce the symptom burden. This model aims to integrate palliative care with standard CF therapies to promote a positive effect on the long-term quality…
News
Multi-drug-resistant nontuberculous mycobacteria (NTM) can be found in the gastric juice and tubes that are used to feed some cystic fibrosis (CF) patients, research shows. Tube feeding, known as gastrostomy, involves surgeons inserting a tube through the abdominal wall and into the stomach. Gastrostomy can also be used to drain…
Yet another consequence of lung infections with the bacterium Pseudomonas (P.) aeruginosa in cystic fibrosis (CF) patients has been discovered, researchers report. But this time, it may be to the disadvantage of the microbe. Another type of bacteria, normally only present on teeth, can hijack Pseudomonas factors to prevent its…
A new test able to screen for the risk for inherited conditions such as cystic fibrosis (CF) will be jointly commercialized by SYNLAB and Counsyl, two companies dedicated to the development of genetic screening tests. Under a new agreement signed by the two companies, SYNLAB will offer Counsyl’s…
A way of treating drug-resistant bacterial infections in people with cystic fibrosis (CF) that draws on preventing the bacteria from taking hold in the lung — through the use of histidine kinase inhibitors — was the focus of a recent review. The study, by scientists at Wageningen University & Research, Netherlands, is titled “…
A large Irish study found that patients with cystic fibrosis (CF) who have lung infections with both Aspergillus fumigatus (AF) and Pseudomonas aeruginosa (PA) have a poor prognosis, compared to those with persistent PA infections. Co-colonization with these two microorganisms may contribute to the damage of the airways of these…
Children with cystic fibrosis (CF) used the Spiro PD device by themselves to measure their lung function and take their breathing medication at home, according to its maker, PMD Healthcare. Use of the device led to better lung function, the company reported. It published its study in Global Pediatric Health under the…
Doctors may soon diagnose cystic fibrosis (CF) with the help of a wristband, thanks to a new wearable sweat analysis tool that measures the molecular constituents of sweat, such as chloride ions and glucose. The device is an upgrade from earlier sweat analysis tools that required patients to be still for up to…
Running a full marathon isn’t a piece of cake for trained athletes, let alone people who struggle to breathe under normal circumstances. Yet two Spaniards with cystic fibrosis (CF) will be among the 40,000 people running in Madrid’s Rock ‘n’ Roll Marathon on Sunday, April 23. The annual 42-kilometer race, which…
The United States and Canada have given Laurent Pharmaceuticals a green light for a Phase 2 clinical trial of LAU-7b as a treatment for cystic fibrosis (CF) in adults. The Phase 2 door was opened when the U.S. Food and Drug Administration (FDA) and Health Canada approved the company’s investigational new drug (IND) application…
Your CF Community
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.